1. Signaling Pathways
  2. Immune Checkpoint

Immune Checkpoint (免疫检查点)

免疫检查点(Immune Checkpoint)是免疫系统中调节免疫应答的分子。免疫检查点可确保免疫系统攻击外来病原体(如细菌、病毒等)时不过度损害正常组织(维持自身耐受、防止自身免疫反应等)。因此,免疫检查点会被一些肿瘤细胞或感染性疾病的病原体利用而逃避免疫攻击。因而,免疫检查点抑制剂越来越多地应用到癌症免疫疗法中。免疫检查点抑制剂可以增强免疫系统对肿瘤细胞的攻击,或阻断抑制性检查点(如 CTLA-4、PD-1),从而恢复有效的 T 细胞功能。总的来说,免疫检查点是一种调节免疫应答的生物学机制,对于免疫系统的正常功能和免疫治疗的发展都具有重要意义。

Immune checkpoints are molecules in the immune system that regulate immune responses. Immune checkpoints ensure that the immune system attacks foreign pathogens (such as bacteria, viruses, etc.) without excessively damaging normal tissues (maintaining self-tolerance, preventing autoimmune responses, etc.). Therefore, immune checkpoints will be used by some tumor cells or pathogens of infectious diseases to escape immune attack. Therefore, immune checkpoint inhibitors are increasingly used in cancer immunotherapy. Immune checkpoint inhibitors can enhance the immune system's attack on tumor cells, or block inhibitory checkpoints (such as CTLA-4, PD-1), thereby restoring effective T cell function. Overall, immune checkpoints are a biological mechanism that regulates immune responses, and are of great significance for the normal function of the immune system and the development of immunotherapy.

Immune Checkpoint 相关产品 (1):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-P99117
    Cadonilimab

    卡度尼利单抗

    99.29%
    Cadonilimab (AK104) 是一种人源化四价 IgG1 双特异性抗体,靶向 PD1/CTLA4。Cadonilimab 阻断 PD-1CTLA-4 通路,从而缓解其相应的免疫抑制作用,逆转肿瘤特异性 T 细胞衰竭。Cadonilimab 显著下调 FC 介导的效应功能,包括抗体依赖性细胞介导的细胞毒性 (ADCC)、抗体依赖性细胞吞噬 (ADCP)、补体依赖性细胞毒性 (CDC)。Cadonilimab 可用于转移性宫颈癌,其他恶性肿瘤如胃癌、GEJ 腺癌、非小细胞肺癌 (NSCLC) 的研究。
    Cadonilimab